CLINUVEL PHARMACEUT. ORDINARY (CUV) Short Interest
CLINUVEL PHARMACEUT. ORDINARY (ASX:CUV) had 9.12% of shares reported as short positions as of 16 May 2026, representing 4,600,146 shares. CLINUVEL PHARMACEUT. ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 9.12%
- Reported positions
- 4,600,146
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
CUV
Clinuvel Pharmaceuticals
Clinuvel Pharmaceuticals Ltd. is a pioneering Australian company specializing in the development of innovative treatments for UV and light-related skin disorders. Their flagship product, SCENESSE®, is the first systemic photoprotective drug approved for preventing phototoxicity in patients with erythropoietic protoporphyria. The company leverages its expertise in photomedicine and melanocortin pep...